Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: A randomised controlled trial
The Lancet Respiratory Medicine Jan 05, 2018
Price DB, et al. - The link between baseline fractional exhaled nitric oxide (FeNO) and the response to inhaled corticosteroids was assessed in patients with non-specific respiratory symptoms. In this work, researchers reported that for clinical use, FeNO measurement is an easy and non-invasive tool to predict response to inhaled corticosteroids in patients with non-specific respiratory symptoms.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
